期刊文献+

181例肺腺鳞癌患者术后预后因素分析 被引量:5

Analysis of the Prognostic Factors in Resection of 181 Patients with Adenosquamous Lung Carcinoma
下载PDF
导出
摘要 目的:探讨术后Ⅰ~Ⅲ期肺腺鳞癌患者的预后及其影响因素。方法:按照2009年国际肺癌研究协会公布的新版肺癌分期标准进行分期,回顾性分析1994年1月至2008年12月天津医科大学附属肿瘤医院收治181例手术切除的Ⅰ~Ⅲ期肺腺鳞癌患者的临床资料,对影响其预后的各因素进行了单因素及多因素分析。结果:全组患者3、5年生存率分别为30.9%、19.0%,中位生存期23.0个月。单因素分析显示淋巴结清扫方式、T分期、N分期、辅助化疗周期数是影响预后的重要因素(P<0.05)。多因素分析结果显示淋巴结清扫方式(P=0.046)、T分期(P=0.006)、N分期(P<0.001)、辅助化疗周期数(P=0.031)是影响预后的独立因素。结论:肺腺鳞癌整体预后差。系统性淋巴结清扫能显著提高肺腺鳞癌患者生存时间。肿瘤的T分期越高其生存率越低,无区域淋巴结转移组生存率较高。Ⅲ期肺腺鳞癌患者可从术后辅助化疗中获益,应至少行4个化疗周期。 Objective: To analyze the prognostic factors in the resection of stage I to stage ]]I adenosquamous lung carcinoma. Methods: From January 1994 to December 2008, 181 surgically treated patients with adenosquamous lung carcinoma were retrospec- tively investigated based on the 2009 International Association for the Study of Lung Cancer (IASLC) tumor - lymph node-metastasis classification. The correlation between clinicopathologic characteristics and prognosis was evaluated using univariate and multivariate analyses. Results: The overall 3- and 5-year survival rates were 30.9% and 19.0%, respectively, and the median survival time was 23.0 months. By univariate analysis, lymph node resection approach, tumor (T) stage, lymph node stage, and the number of chemotherapy cycles were significantly related to patient survival (P〈0.05). By multivariate analysis, lymph node resection approach (P=0.046), T stage (P=0.006), N stage (P〈0.001), and the number of chemotherapy cycles (P=0.03 I) were independent prognostic factors. Conclu- sion: The overall survival rate of adenosquamous lung carcinoma was low. Radical systematic mediastinal lymphadenectomy is the sur- gical treatment of choice for adenosquamous lung carcinoma. The survival rates at stages T1 to T4 gradually decreased. The patients without lymph node involvement (NO) had longer survival periods than those with N1 and N2 lymph node involvement. Chemotherapy significant improves the survival of patients with stage m disease. Chemotherapy cycle should consist of at least 4 cycles.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2012年第21期1656-1659,共4页 Chinese Journal of Clinical Oncology
关键词 肺腺鳞癌 手术治疗 辅助化疗 预后 Adenosquamous carcinoma of the lung Surgical treatment Adjuvant chemotherapy Prognosis
  • 相关文献

参考文献12

  • 1Shelton DA, Rana DN, Holbrook M, et al. Adenosquamous carci- noma of the lung diagnosed by cytology? A diagnostic dilenmaa[J]. Diagn Cytopathol, 2 011.[Epub ahead of print].
  • 2Maeda H, Matsumura A, Kawabata T, et al. Adenosquamous carci- noma of the lung: surgical results as compared with squamous cell and adenocarcinoma cases[J].EurJ Gardiothorac Surg, 2012, 41(2): 357-361.
  • 3Nakagawa K, Yasumitu T, Fukuhara K, et al. Poor prognosis after lung resection for patients with adenosquamous carcinoma of the lung[J]. Ann Thorac Surg, 2003, 75(6):1740-1744.
  • 4Shundo Y, Takahashi T, Itaya T, et al. Clinical study of forty-two patients who underwent resection for pulmonary adenosquamous carcinoma[J]. Kyobu Geka, 2011, 64(10):871-876.
  • 5李鉴,张德超,赫捷,刘向阳,牟巨伟,张良泽.肺腺鳞癌淋巴结转移规律的探讨[J].中华肿瘤杂志,2009,31(7):524-527. 被引量:5
  • 6王长利,岳东升,张真发,宫立群,苏延军,尤健,张振,谷峰.非小细胞肺癌1638例治疗及预后探讨[J].中华外科杂志,2011,49(7):618-622. 被引量:24
  • 7Douillard JY, Rosell R, De Lena M, et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resect- ed stage I B-Ⅲ A non-small-cell lung cancer (Adjuvant Navel- bine International Trialist Association [ANITA]) a randomised con- trolled triM[J]. Lancet Oncol, 2006, 7(10):797.
  • 8Suehisa H, Toyooka S. Adjuvant chemotherapy for completely re- sected non-small-cell lung cancer[J].Acta Med Okayama, 2009,63 (5) :223-230.
  • 9Gawrychowski J, Brulinski K, Malinowski E, et al. Prognosis and survival after radical resection of primary adenosquamous lung car- cinoma[J]. EurJ Cardiothorac Surg, 2005, 27(4):686-692.
  • 10Filosso PL, Ruff.aft E, Asioli S, et al. Adenosquarnous lung carcino- mas: a histologic subtype with poor prognosis[J]. Lung Cancer, 2011, 74(1):25-29.

二级参考文献36

  • 1廖美琳,徐昌文,黄偶麟,吴善芳,吴松昌,周允中,孙德魁,林震琼,杨子培.Ⅲ期肺癌手术治疗生存率的分析[J].实用肿瘤杂志,1993,8(1):10-13. 被引量:8
  • 2Nakagawa K, Yasumitu T, Fukuhara K, et al. Poor prognosis after lung resection for patients with adenosquamous carcinoma of the lung. Ann Thorac Surg, 2003, 75:1740-1744.
  • 3Pelletier MP, Edwardes MD, Michel RP, et al. Prognostic markers in resectable non-small cell lung cancer: a multivariate analysis. Can J Surg, 2001,44:180-188.
  • 4Ohawada H. Histological classification of lung cancer ( Japan Lung Cancer Society). Nippon Rinsho, 2002, 60 Suppl 5:132-137.
  • 5Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest, 1997, 111 : 1710-1723.
  • 6Kotoulas CS, Foroulis CN, Kostikas K, et al. Involvement of lymphatic metastatic spread in non-small cell lung cancer accordingly to the primary cancer location. Lung Cancer, 2004, 44 : 183-191.
  • 7Keller SM, Vangel MG, Wagner H, et al. Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease. J Thorac Cardiovasc Surg, 2004, 128 : 130-137.
  • 8Riquet M, Perrotin C, Lang-Lazdunski L, et al. Do patients with adenosquamous carcinoma of the lung need a more aggressive approach? J Thorac Cardiovasc Surg, 2001, 122:618-619.
  • 9Inoue M, Sawabata N, Takeda S, et al. Results of surgical imervention for p-stage III A (N2) non-small cell lung cancer: acceptable prognosis predicted by complete resection in patients with single N2 disease with primary tumor in the upper lobe. J Thorac Cardiovasc Surg, 2004, 127 : 1100-1106.
  • 10Feng Q, Wang M, Wang L, et al. A study of postoperative radiotherapy in patients with non-small-cell lung cancer randomized trial, Int J Radiat Oncol Biol Phys, 2000, 47(4): 925-929.

共引文献37

同被引文献18

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部